A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies

Summary

The primary objective is to determine overall survival 180 days after transplantation involving HLA-haploidentical stem cell/bone marrow graft, and post-transplant Cy.

Timeline

Start

2012-09-21

Primary completion

2016-05-12

Completion

2023-01-01

Outcome

Outcome not reported

Stopped: “Toxicity”

Drugs

Indications